InsiderTrades

Form 4 for ZYME Zymeworks Inc.

Accepted 2023-12-11 00:00:00 ET · period of report 2023-12-11 · accession 0000950170-23-069496 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-11 2023-12-11 ZYME Astle Christopher SVP, CFO S - Sale+OE $9.13 -886 1,997 -31% -$8,089
D 2023-12-11 2023-12-11 ZYME Astle Christopher SVP, CFO M - OptEx $0.00 +1,550 2,883 +116% $0
D 2023-12-11 2023-12-11 ZYME Astle Christopher SVP, CFO M - OptEx $0.00 -1,550 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-11 S D 886 $9.13 1,997 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.11 to $9.16, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2023-12-11 M A 1,550 $0.00 2,883 D — — (F1) Represents shares of common stock issued upon vesting of one half of the restricted stock units ("RSUs") granted on December 10, 2021.
3 Derivative Restricted Stock Unit 2023-12-11 M D 1,550 $0.00 0 D — · — to — 1,550 Common Stock (F4) Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. (F5) The RSUs were granted on December 10, 2021 and vested in two equal annual instalments (on December 12, 2022 and December 11, 2023).